Top Rated Pharma Companies to Work for 2025

Global pharmaceutical leader, reporting over ₹20,000 crore in FY24 revenue and a leading global manufacturer of generic medicines with a product footprint in more than 100 countries.

Global leader in pharmaceuticals, championing affordable healthcare with over ₹25,000 crore in revenue, driving innovation across respiratory, oncology, and HIV treatments.

Global leader in the pharmaceutical industry, specializing in generics, biosimilars, and active pharmaceutical ingredients.

Global pharmaceutical leader, delivering affordable, high-quality medicines. With a focus on innovation, it generated ₹279.2 billion in revenue, advancing healthcare.

One of India's largest pharmaceutical company and one of the world's largest specialty generics firms, reporting ₹47,758 crore in FY24 revenue and a global footprint in more than 100 countries.

Leading Indian pharmaceutical company specializing in APIs and formulations, with a history of launching innovative generic medicines.

Leading Indian biopharma firm supplying vaccines to 130+ countries, known for producing over 2 billion COVID-19 doses and advancing global immunization efforts.

Leading pharma and biotech firm, delivering high-quality APIs, formulations, and biotech solutions, generating over ₹5,000 crore in revenue with global impact across 50+ countries.

Global healthcare company focusing on expanding access to medicines, achieving $14.7 billion in revenue in 2024 and serving patients in over 165 countries.

Global healthcare leader, achieving $42.1 billion in 2024 revenue, expanding its reach to over 45 million patients, and investing in production capacity to meet growing demand.